The future of excipients is here: Meet DFE Pharma at CPHI
DFE Pharma invites you to join us at CPHI Frankfurt, where we will showcase the innovations shaping the future of pharmaceutical excipients. At the heart of our presence is EcoLact 2030—our CO₂-verified lactose designed to support the industry’s transition toward more sustainable formulation practices.
EcoLact 2030: Measurable impact, no regulatory complexity
EcoLact 2030 enables pharmaceutical manufacturers to accelerate their Scope 3 CO₂ reduction goals with:
- Verified 30% CO₂ reduction, supported by traceable, farm-level data
- Full value-chain transparency, ensuring accountability across sourcing and production
- No regulatory complexities, maintaining continuity with trusted brands
This innovation reflects our commitment to responsible progress—delivering sustainability without compromise.
Technical leadership in nitrosamine risk mitigation
DFE Pharma continues to lead in supporting nitrosamine compliance through:
- A low-nitrite excipient portfolio, including MCC, lactose, and superdisintegrants
- The Nitrosamine Calculator, a digital tool to assess risk and guide excipient selection
- Transparent data, with nitrite levels declared on every Certificate of Analysis
Our technical experts are available to help you navigate regulatory expectations with confidence.
Security of Supply You Can Rely On
With a certified Business Continuity Management System, global manufacturing footprint, and strategic warehousing, DFE Pharma ensures:
- Reliable availability of excipients
- Shorter lead times
- Resilience across the supply chain
Partnering for a Healthier Future
DFE Pharma is committed to advancing patient care responsibly—today and into the future. Visit our booth at CPHI to explore how our solutions can support your formulation goals.